header advert
Results 21 - 24 of 24
Results per page:
Applied filters
Content I can access

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 85-B, Issue SUPP_II | Pages 170 - 170
1 Feb 2003
Al-lami M Fender D Khaw F Sandher D Esler C Harper W Gregg P
Full Access

The National Institute for Clinical Excellence (NICE), in its “Guidance on the Selection of Prostheses for Primary Total Hip Replacement”, states that a revision rate of 10% or less at ten years should be regarded as the “benchmark” in the selection of prostheses for primary Total Hip Replacement (THR). This paper presents the results of such a study for primary Charnley THR. Methods: All patients undergoing primary Charnley THR during 1990 were prospectively registered with the Trent Regional Arthroplasty Study (TRAS). During 1990, 1198 Charnley THRs were performed on 1152 patients, under the care of 56 consultants, in 18 National Health Service and 6 private hospitals. The cohort contains 39.0% male and 61.0% female patients, with an average age at operation of 69.1years (21–103 years), 19.1% being less than 60 years. At 10 years all surviving patients at 5 years were registered with the ONS to ascertain living patients. These patients were contacted by letter to determine whether or not their THR had been revised. The status of the THR, for non-responding patients, was determined by contacting the patient’s GP through the Contractor Services Agency (CSA). The endpoint was defined as revision surgery to replace an original implant component. Results: At 10 years, the recipients of 438 THRs had died. The recipients of 89 THRs did not respond to the questionnaire at ten years. Implant status at ten years, in living patients was known for 671 of 760 (88.3%) THRs. The ten-year crude revision rate was 44 out of 1198 (3.7%) and cumulative survival rate was 95.5% (95% CI, 93.6% – 96.9%).

Conclusion: This is the first study to assess the survivorship at 10 years for primary Charnley THRs performed in the ‘general setting’ of the NHS as opposed to specialist centres and shows a result well within the NICE benchmark.


Orthopaedic Proceedings
Vol. 85-B, Issue SUPP_I | Pages 29 - 29
1 Jan 2003
Khaw F Kirk L Gregg P
Full Access

Cementless fixation for total knee arthroplasty (TKA) has been proposed as an alternative to cemented for several reasons, of which the most important is the possibility of increased survival. The purpose of this study was to compare the ten-year survival of TKA in a unique prospective randomised trial of cemented versus cementless fixation.

A consecutive series of patients was randomised to undergo either cemented or cementless Press-Fit Condylar (PFC®) TKA. There were 219 patients (277 TKA) in the cemented group and 177 (224 TKA) in the cementless group. There were no significant differences in age, gender or diagnosis between the two groups.

A single surgeon (PJG) performed or directly supervised all operations. The prosthesis used in all cases was the posterior-cruciate-retaining PFC® knee replacement system. Independent clinical review was performed at six months, annually until five years, and finally at ten years after surgery. Using revision surgery as the end-point, logrank analysis was used to compare the ten-year survival of the two groups.

The mean interval of follow-up was 6.3 years (range, 2.0–11.7). At the last review, 104 patients (138 TKA) had died, without need for revision. All patients were traced and there was no loss to follow-up. In the cemented group, seven arthroplasties were revised; five for infection and two for exchange of polyethylene inserts. Ten-year survival was 96.5% (95% CI, 90.9–98.7%). In the cementless group, six arthroplasties were revised; three for aseptic loosening, one for infection, one for instability and one resizing for anterior knee pain. The ten-year survival was 96.6% (95% CI, 89.6–98.9%). There was no significant difference in the survival of the two groups.

The long-term survival of cementless PFC® TKA is not significantly different from their cemented counterparts. The use of less expensive cemented implants, therefore, can make a significant impact on health resource planning.


Orthopaedic Proceedings
Vol. 85-B, Issue SUPP_I | Pages 34 - 35
1 Jan 2003
Chambers I Fender D McCaskie A Gregg P
Full Access

To establish whether there were features present on the initial post-operative radiographs of total hip replacements (THR) predictive of aseptic loosening.

Our data was derived from the Trent Regional Arthroplasty Study (TRAS) which is the only hip register of its kind in the country. The TRAS commenced in 1990 and has recorded clinical and operative details of all THRs in the region.

Our current study was concerned with a cohort of grossly loose THRs, identified from the five-year follow up of those patients who had undergone THR in 1990. Our cohort are those which failed specifically due to aseptic loosening and comprises those revised or listed for revision as well as a number of previously undiagnosed cases.

The post-operative radiographs were analysed, recording the following: (1) number, width and location (Gruen zone) of radiolucencies at both cement-bone and cement-prosthesis interfaces; (2) presence of stem-cortex contact; (3) width of the cement mantle in each Gruen zone; and (4) Barrack cementation grade.

Occasionally, if the initial post-operative radiograph was of poor quality, then further information was gained from the next available ones (usually at six weeks) to improve accuracy.

Comparisons were made with 60 control hips randomly generated from the same 1990 cohort but which had not failed.

Chi-squared tests were used to test the probability of obtaining the observed data by chance and odds ratios were calculated to describe relative risk of failure for different risk factors.

Hips with inadequate cementation grades (C and D) had a 9.5 times greater risk of failure compared to those with adequate cementation grades (A and B) [p< 0.0001].

We have demonstrated that the grade of cementation has a major effect on the probability of failure. This emphasises the importance of good cementing, which is particularly relevant in this era of clinical governance where there is greater accountability on the surgeon for adequate performance.


Orthopaedic Proceedings
Vol. 85-B, Issue SUPP_I | Pages 13 - 14
1 Jan 2003
Burt N Green S Sandher D Gregg P
Full Access

Cementation is an important part of arthroplasty operations. Recent publication of results of Charnley total hip replacement found a rate of early aseptic loosening of 2.3% at 5 years following surgery across a NHS region. There are possibly many reasons for early loosening but precise reasons are still not fully understood, however, it is felt that cementation technique is very important. There seems to be a number of factors involved such as cement mixing techniques and conditions, physical properties of the cement, cementation and surgical techniques, bone-cement interface as well as bone- prosthesis interface. The purpose of this study was to evaluate the effectiveness of the clinical environment in producing bone cement of predictable mechanical and physical properties, and how those properties compare with published data. The investigation compared samples of bone cement, taken from material prepared and used in surgery with cement samples prepared under controlled laboratory conditions and in accordance with ISO materials testing standards.

During 2000–01, 10 total hip replacements were selected for study. All operations involved the use of CMW1 (DePuy) radio-opaque cement, which was mixed using the Vacumix system. In this cohort, all femoral cementations were performed using an 80g cement mix. After careful preparation of the femoral canal, the scrub nurse mixed the cement in accordance with the manufacturer’s instructions. The cement was introduced into the femoral canal, via a nozzle, using the cementation gun and a pressurizer. Following introduction of cement into the canal, the nozzle and cement contained within, was broken off the gun distal to the pressurizer. Once cured, the cement samples were removed from the nozzle, sectioned, and mechanically tested. Due to this novel sample preparation procedure, the tested cement was expected to exhibit mechanical and physical properties characteristic of the cement present in the femoral canal. Samples of CMW1 (Vacumixed) of similar mass and aspect ratio were produced within the laboratory, in accordance with the manufacturers mixing instructions. PMMA bone cement is a brittle, glassy polymer that is susceptible to stress raisers, such as pores, which can reduce the load carrying ability, which in vivo is predominantly compressive in nature. Published mechanical properties of PMMA bone cement vary somewhat, reflecting the dependence of properties on flaw distribution. The density, which provides a measure of porosity, hardness and ultimate compressive strength of the cement samples was measured and compared.

The surgical samples were found to be very consistent in compressive strength (121 ± 6 MPa), density (1.20 ± 0.02 gcm−3) and hardness (23.2 ± 1.6 VHN) and closely matched the mechanical properties of the cement mixed in the laboratory.

This study suggests that for the studied cement and mixing regime, the clinical environment is capable of producing a well-controlled cement product that has reproducible and predictable mechanical properties. Further, the novel sample preparation procedure used suggests that the cement within the femoral cavity should demonstrate equally predictable, mechanical and physical properties.